Analyst consensus rating
Bio-Techne Analyst Rating: none
Direct answer
Bio-Techne's consensus rating is none.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $70.73.
Forecast evidence checked September 18, 2026.
Get free Bio-Techne email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $72.36
- Average price target
- $70.73
- High price target
- $73.00
- Low price target
- $50.00
- Low target gap
- -30.9%
- Target upside
- -2.2%
- High target gap
- +0.9%
- Target range width
- 31.8%
- Consensus rating
- none
- Analysts
- 11
- Evidence date
- September 18, 2026
- Valid through
- September 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Bio-Techne?
Bio-Techne has a verified none consensus. The same dataset has an average price target of $70.73.
How far are Bio-Techne's low and high targets from the recorded price?
The low target implies -30.9%, while the high target implies +0.9%.
How many analysts are included in Bio-Techne's consensus?
The verified consensus includes 11 analysts.
How is Bio-Techne's target upside or downside calculated?
The average target of $70.73 is divided by the recorded price of $72.36, then one is subtracted to produce -2.2%. This does not guarantee a future return.
When was Bio-Techne's analyst forecast verified?
The data was verified on 2026-09-18. The dataset is valid through 2026-09-25.